Curative Biotechnology Inc (CUBT)

[My911Voice]

If we have such a great story to tell about how great this Metformin eye drop could be for AMD patients, how come the founders and advisors with years of industry experience have been unable to make any visible progress month after month after month? Wouldn’t venture money be pouring in with the market potential being so large and Curative having exclusivity?

I get that drug discovery takes time, but we are not stopped with a science problem or hung up in a lengthy clinical trial process. We are stalled for other reasons. Somewhere Curative has a problem of credibility, incompetence or dishonesty (or maybe some combination). On paper, this team should be able to make progress and use their connections to bring in the funding to get things moving, but that has not been happening.

Let’s go already!!